Identification of a Novel Prognostic Signature Related to PANoptosis and Its Regulatory Mechanism as Well as Targeted Treatment of Active Ingredients and Traditional Chinese Medicine in Lung Adenocarcinoma

Shaohui Wang,Ya Hou,Nan Xing,Xianli Meng,Yi Zhang,Xiaobo Wang,xiaobo wang

DOI: https://doi.org/10.2139/ssrn.4016078

2022-01-01

SSRN Electronic Journal

Abstract:Lung adenocarcinoma with a poor prognosis is the most common type of lung cancer, and one of the most aggressive and rapidly fatal tumor types. PANoptosis is a newly identified pro-inflammatory programmed cell death pathway controlled by the recently discovered cytoplasmic polymeric protein complex is called a PANoptosome. PANoptosome Components are linked to a variety of human diseases, including autoinflammatory diseases, cancer, etc.. However, the specific effect of PANoptosis regulatory factors in regulating the prognosis and potential mechanism in lung adenocarcinoma is unclear. Here, we ultimately identified 14 differentially expressed PANoptosis related regulators by comparing unpaired and paired lung adenocarcinoma samples, as well as summarized the genetic mutations and molecular correlations of PANoptosis regulators in LUAD. GO and KEGG pathway analysis showed that these PANoptosis factors were mainly involved in NOD-like receptor signaling pathway, necroptosis, TNF signaling pathway, apoptosis, and IL-17 signaling pathway. PANoptosis related prognostic signature based on three genes (FADD, MAP3K7 and NLRP3) has a good performance in prognostic prediction models of LUAD patients. The validation results showed that the expression trend of FADD gene and protein was in agreement with the previous analysis results of TCGA database. In addition, we found that the expression of FADD was involved in most immune infiltrating cell types. We also found the regulatory axis of lncRNA TUG1/ miR-128-3p /FADD in the progression of LUAD. Besides, we found that resveratrol, quercetin, capsaicin, as well as Silybum Marianum, Schisandra chinensis, Mangifera indica, Panax ginseng are potential therapeutic drugs targeting PANoptosis prognostic signature FADD. In a word, we analyzed and identified a novel PANoptosis related prognostic signature FADD as a potential biomarker for LUAD, and revealed its role in regulating immune microenvironment, as well as found its potential lncRNA TUG1/ miR-128-3p/FADD regulatory axis and targeted therapy TCM and active ingredients, which provides a basis for the development of new targeted immunotherapy drugs.

English Else